QIAGEN NV EO -,01 | 41.310 / +0.41% |
Date/Time | 03/01 / 14:00 |
Chg. / Chg.(%) | 0.170 / +0.41% |
Bid | 41.320 / 250 |
Ask | 41.340 / 250 |
Open | 41.620 |
Previous Close | 41.140 |
High | 41.910 |
Low | 41.180 |
Volume [EUR] | 0.000 |
Volume [Units] | 0 |
Price fixings | 10 |
ISIN | NL0012169213 |
Security | QIA |
Exchange | Düsseldorf |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Xetra | 41.340 | ![]() |
160,260 |
Turquoise | 41.34 | ![]() |
80,498 |
Cboe Europe .. | 41.34 | ![]() |
69,529 |
TradeGate | 41.71 | ![]() |
13,605 |
London Inter.. | 41.37 | ![]() |
7,246 |
Stuttgart | 41.330 | ![]() |
1,190 |
Frankfurt | 41.1500 | ![]() |
1,098 |
gettex | 41.180 | ![]() |
206 |
Hamburg | 42.190 | ![]() |
150 |
Berlin | 41.910 | ![]() |
3 |
München | 41.610 | ![]() |
0 |
Düsseldorf | 41.310 | ![]() |
0 |
Hannover | 41.910 | ![]() |
0 |
Lang & Schwa.. | 41.320 | ![]() |
|
NYSE | 50.00 | ![]() |
919,789 |
IEX | 50.03 | ![]() |
37,140 |
Cboe US | 50.02 | 14,351 | |
Cboe Europe .. | 40.87 | 40 | |
Vienna Globa.. | 40.92 | 0 | |
Cboe Europe .. | 41.48 | 388 | |
EUREX | Options |
News
- OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
12/09/2020 / 13:30 - GlobeNewswire - HTG Molecular Diagnostics Reports Third Quarter 2020 Results
11/10/2020 / 22:01 - GlobeNewswire - Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics
10/06/2020 / 21:30 - GlobeNewswire - Thermo Fisher's acquisition of Qiagen fails
08/13/2020 / 13:48 - TeleTrader - HTG Molecular Diagnostics Reports Second Quarter 2020 Results
08/11/2020 / 22:01 - GlobeNewswire